Julia Sauer1, Joel B Mason, Sang-Woon Choi. 1. Vitamins and Carcinogenesis Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts 02111, USA.
Abstract
PURPOSE OF REVIEW: The intent of this evidence-based review is to analyze the role of folate in chronic diseases, focusing on cancer and cardiovascular disease. RECENT FINDINGS: Low folate status has been shown to be a risk factor for cancer and cardiovascular disease. Although epidemiological data suggest an inverse association between folate status and disease risk, intervention studies give equivocal results, suggesting the response to folate intake does not follow a linear continuum. Moreover, recent folate intervention trials raise concern about possible adverse effects of folate supplementation and suggest that too much folate in inopportune settings may be potentially harmful in individuals at higher risk for cardiovascular disease and cancer. SUMMARY: Although folate intake at sufficient levels appears to be an effective cancer chemopreventive strategy, high-dose supplementation of folate has generally not been effective in reducing recurrence of cardiovascular events or colorectal adenomas in clinical intervention trials. Although controversial, high folate status achieved through folate fortification or supplementation may increase the risk of certain chronic diseases among certain individuals, possibly by interfering with the homeostasis of one-carbon metabolism. Further research is urgently needed to accurately define the relationship between supraphysiological intake of folate and chronic diseases.
PURPOSE OF REVIEW: The intent of this evidence-based review is to analyze the role of folate in chronic diseases, focusing on cancer and cardiovascular disease. RECENT FINDINGS: Low folate status has been shown to be a risk factor for cancer and cardiovascular disease. Although epidemiological data suggest an inverse association between folate status and disease risk, intervention studies give equivocal results, suggesting the response to folate intake does not follow a linear continuum. Moreover, recent folate intervention trials raise concern about possible adverse effects of folate supplementation and suggest that too much folate in inopportune settings may be potentially harmful in individuals at higher risk for cardiovascular disease and cancer. SUMMARY: Although folate intake at sufficient levels appears to be an effective cancer chemopreventive strategy, high-dose supplementation of folate has generally not been effective in reducing recurrence of cardiovascular events or colorectal adenomas in clinical intervention trials. Although controversial, high folate status achieved through folate fortification or supplementation may increase the risk of certain chronic diseases among certain individuals, possibly by interfering with the homeostasis of one-carbon metabolism. Further research is urgently needed to accurately define the relationship between supraphysiological intake of folate and chronic diseases.
Authors: Aron M Troen; Breeana Mitchell; Bess Sorensen; Mark H Wener; Abbey Johnston; Brent Wood; Jacob Selhub; Anne McTiernan; Yutaka Yasui; Evrim Oral; John D Potter; Cornelia M Ulrich Journal: J Nutr Date: 2006-01 Impact factor: 4.798
Authors: Rachael Z Stolzenberg-Solomon; Shih-Chen Chang; Michael F Leitzmann; Karen A Johnson; Christine Johnson; Saundra S Buys; Robert N Hoover; Regina G Ziegler Journal: Am J Clin Nutr Date: 2006-04 Impact factor: 7.045
Authors: María Elena Martínez; Edward Giovannucci; Ruiyun Jiang; Susanne M Henning; Elizabeth T Jacobs; Patricia Thompson; Stephanie A Smith-Warner; David S Alberts Journal: Int J Cancer Date: 2006-09-15 Impact factor: 7.396
Authors: Kaare Harald Bønaa; Inger Njølstad; Per Magne Ueland; Henrik Schirmer; Aage Tverdal; Terje Steigen; Harald Wang; Jan Erik Nordrehaug; Egil Arnesen; Knut Rasmussen Journal: N Engl J Med Date: 2006-03-12 Impact factor: 91.245
Authors: Todd M Gibson; Stephanie J Weinstein; Ruth M Pfeiffer; Albert R Hollenbeck; Amy F Subar; Arthur Schatzkin; Susan T Mayne; Rachael Stolzenberg-Solomon Journal: Am J Clin Nutr Date: 2011-08-03 Impact factor: 7.045
Authors: Amanda J MacFarlane; Nathalie A Behan; Martha S Field; Andrew Williams; Patrick J Stover; Carole L Yauk Journal: Mutat Res Date: 2015-06-29 Impact factor: 2.433
Authors: Caroline E Boeke; Andrea Baccarelli; Ken P Kleinman; Heather H Burris; Augusto A Litonjua; Sheryl L Rifas-Shiman; Letizia Tarantini; Matthew Gillman Journal: Epigenetics Date: 2012-03 Impact factor: 4.528